Clinical trial
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 · Sorlandet Hospital HF, Other · Completed
Key facts
| NCT number | NCT00138801 |
|---|---|
| Title | Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis |
| Official title | Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis. A Randomized Double-blind Comparison |
| Lead sponsor | Sorlandet Hospital HF, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lyme Neuroborreliosis |
| Intervention type | Drug |
| Interventions | Ceftriaxone, Doxycycline |
| Enrollment | 120 |
| Start date | Mar 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 30, 2005 |
| Last update posted | May 6, 2023 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: